FDA Approves First Digital Pill That Can Tracks Medicine when swallowed

First Digital Pill

For the first time Food and Drug Administration have approved the primary First Digital Pill together with Abilify with an embedded detector to trace if patients are taking their medication properly, marking a significant success in the convergence of healthcare and technology.The medicine is a version of Otsuka Pharmaceutical Co Ltd’s established drug Abilify whereas … Read moreFDA Approves First Digital Pill That Can Tracks Medicine when swallowed

FDA approves Hemlibra-To Prevent Bleeding In Hemophilia A

Hemlibra

The U.S. Food and Drug Administration on November 16, 2017  approved Hemlibra (emicizumab-kxwh) to stop or scale back the frequency of bleeding episodes in adult and paediatric patients with hemophilia A who have developed antibodies known as factor viii (FVIII) inhibitors.The Fda Granted approval to Genentech, Inc. Hemophilia A is an hereditary blood disorder that primarily … Read moreFDA approves Hemlibra-To Prevent Bleeding In Hemophilia A

New FDA Approved Drugs 2017

FDA Approved Drugs 2017

Following are the list of FDA Approved Drugs 2017 List For sale in United states.Information In This List Include; Date of Approval, Drug Name, its active drug And Uses. FDA Approved Drugs 2017 List Jan-19-2017: Trulance (Active: Plecanatide)approved for the treatment of Chronic idiopathic constipation in Adult Patients. Feb-8-2017: Parsabiv (Active: Etelcalcetide) Approved for the … Read moreNew FDA Approved Drugs 2017

FDA approves new treatment for hepatitis c

Mavyret

The U.S. Food and Drug Administration on Thursday 03/08/2017  approved a new treatment for hepatitis c i.e Mavyret (glecaprevir and pibrentasvir) to treat All Major Strain Of Hepatitis C without cirrhosis (liver disease) or with mild liver disease, including patients with moderate to severe renal disorder and people who are on dialysis. The FDA granted … Read moreFDA approves new treatment for hepatitis c